Skip to main content

Parkinsonism News (Page 3)

Alzheimer, Parkinson Disease Share Protective Association at HLA Locus

FRIDAY, Sept. 8, 2023 – Alzheimer disease (AD) and Parkinson disease (PD) share the same protective association at the human leukocyte antigen (HLA) locus, according to a study published online Aug....

Mitch McConnell's Recent Episodes Weren't Strokes or Seizures, Capitol Doc Says

TUESDAY, Sept. 5, 2023 – The two "freezing" episodes that Sen. Mitch McConnell experienced recently weren't strokes or seizures, the Capitol physician said in a new letter released Tuesday. “My e...

Gut Troubles Could Be Early Signal of Parkinson's Disease

FRIDAY, Aug. 25, 2023 – It might not seem like constipation or difficulty swallowing could signal a neurological problem, but new research suggests that these gut conditions could be an early...

Specific GI Syndromes Linked to Parkinson Disease

FRIDAY, Aug. 25, 2023 – Specific gastrointestinal (GI) syndromes including dysphagia, gastroparesis, constipation, and irritable bowel syndrome (IBS) without diarrhea are associated with Parkinson...

Thickness of GCIPL, INL of Retina Reduced in Parkinson Disease

THURSDAY, Aug. 24, 2023 – Reduced thickness of the ganglion cell-inner plexiform layer (GCIPL) and inner nuclear layer (INL) of the retina are seen in individuals with Parkinson disease (PD),...

Eye Scans Could Spot Parkinson's in Earliest Stages

TUESDAY, Aug. 22, 2023 – British researchers may have found a way to diagnose Parkinson’s disease several years sooner. Researchers at University College London and Moorfields Eye Hospital say that e...

Playing Football Tied to Higher Risk of Parkinsonism, Parkinson Disease

TUESDAY, Aug. 15, 2023 – Past participation in football is associated with higher odds of having a reported parkinsonism or Parkinson disease (PD) diagnosis, according to a study published online...

FDA Approves Ongentys (opicapone) as an Add-On Treatment for Patients with Parkinson’s Disease Experiencing “Off” Episodes

SAN DIEGO – April 27, 2020 – Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily oral Ongentys (opicapone) 25 mg and 50...

FDA Approves Xadago (safinamide) as an Add-On Treatment for Patients with Parkinson’s Disease

March 21, 2017 – The U.S. Food and Drug Administration today approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s disease who are currently taking l...

FDA Medwatch Alert: Benztropine Mesylate Injection (Nexus Pharmaceuticals): Recall - Visible Particulate Matter

ISSUE: Nexus Pharmaceuticals Inc. is recalling two lots of Benztropine Mesylate Injection, USP, 2 mg/2mL (1mg/mL) in 2 mL single dose vials due to the presence of visible particulate matter in the...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Parkinson's Disease

Related drug support groups

levodopa